Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02545: Variant p.Arg541Ser

Prelamin-A/C
Gene: LMNA
Feedback?
Variant information Variant position: help 541 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Serine (S) at position 541 (R541S, p.Arg541Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In EDMD2 and CMD1A; modest and non-specific nuclear membrane alterations; the phenotype is entirely reversed by coexpression of the S-541 mutation and wild-type lamin-C. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 541 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 664 The length of the canonical sequence.
Location on the sequence: help GCGNSLRTALINSTGEEVAM R KLVRSVTVVEDDEDEDGDDL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GCGNSLRTALINSTGEEVAMRKLVRSVTVVED--DEDEDGDDL

Mouse                         GCGSSLRTALINSTGEEVAMRKLVRSLTMVEDNEDDDEDGE

Rat                           GCGTSLRTALINATGEEVAMRKLVRSLTMVEDNDDEEEDGD

Pig                           GCGNSLRTALINSTGEEVAMRKLVRSVTMIED--DEDEDGD

Chicken                       GSGDSLRTALINSNGEEVAMRKLVRTVIINDDDEDEEDDEV

Xenopus laevis                GTGDSIRTALLTSSNEEVAMRKLVRTVVINDEDDEDNDDME

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 661 Prelamin-A/C
Chain 1 – 646 Lamin-A/C
Domain 428 – 545 LTD
Region 384 – 664 Tail
Modified residue 533 – 533 Phosphoserine
Modified residue 546 – 546 Phosphoserine
Modified residue 548 – 548 Phosphothreonine
Alternative sequence 537 – 566 Missing. In isoform ADelta10.
Beta strand 537 – 543



Literature citations
In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
Sylvius N.; Bilinska Z.T.; Veinot J.P.; Fidzianska A.; Bolongo P.M.; Poon S.; McKeown P.; Davies R.A.; Chan K.-L.; Tang A.S.L.; Dyack S.; Grzybowski J.; Ruzyllo W.; McBride H.; Tesson F.;
J. Med. Genet. 42:639-647(2005)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A); SUBCELLULAR LOCATION (ISOFORM C); VARIANTS CMD1A TRP-190; GLY-192 AND SER-541; CHARACTERIZATION OF VARIANTS CMD1A GLY-192 AND SER-541; Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations.
Scharner J.; Brown C.A.; Bower M.; Iannaccone S.T.; Khatri I.A.; Escolar D.; Gordon E.; Felice K.; Crowe C.A.; Grosmann C.; Meriggioli M.N.; Asamoah A.; Gordon O.; Gnocchi V.F.; Ellis J.A.; Mendell J.R.; Zammit P.S.;
Hum. Mutat. 32:152-167(2011)
Cited for: VARIANTS EDMD2 SER-39; CYS-45; PRO-150; PRO-189; ARG-190 INS; LEU-206; TRP-249; GLN-249; PRO-268; PRO-271; PRO-294; PRO-295; PRO-303; GLN-355 DEL; LYS-358; LYS-361; LYS-386; ASP-449; TRP-453; PRO-454; TYR-461; ARG-467; PRO-527; LYS-528; ARG-528; SER-541; PRO-541; SER-602 AND CYS-644; CHARACTERIZATION OF VARIANTS EDMD2 PRO-25; TRP-249; ILE-456 AND PRO-541;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.